Methods of detecting and treating cerebral aneurysms
AssigneesUniversity Pf Pittsburgh - of the Commonwealth System of Higher Eduction, Upmc
InventorsRobert Max Friedlander, Ali A. Alattar, Kamil W. Nowicki, Michael M. McDowell, Aditya M. Mittal
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a whole blood, protein-based diagnostic test for presence of unruptured aneurysms and allow for tracking progression of unruptured, ruptured, and previously treated aneurysms to guide clinical decision making. Further, the present disclosure relates to methods of treating aneurysms.
Claims20
A method of treating an aneurysm in a subject in need thereof, comprising
- a) measuring, in a biological sample of the subject, an expression level of (i) I-309, IL-16, IL-1 alpha, MCP-2, MIP-1 delta, and/or uPAR, (ii) I-309, IL-16, MCP-4, MIP-1 delta, CXCL7/NAP-2 and/or uPAR, or (iii) FasL and/or CCL22;
- b) identifying the subject as having an aneurysm if the expression level of (i) I-309, IL-16, IL-1 alpha, MCP-2, MIP-1 delta, and/or uPAR, (ii) I-309, IL-16, MCP-4, MIP-1 delta, CXCL7/NAP-2 and/or uPAR, or (iii) FasL and/or CCL22 is increased relative to a first reference sample;
- and
- c) administering an effective amount of an aneurysm inhibitor to the subject.
A method for preventing or reducing the risk of growth and/or rupture of an aneurysm in a subject in need thereof, comprising:
- a) measuring, in a biological sample of the subject, an expression level of (i) I-309, IL-16, IL-1 alpha, MCP-2, MIP-1 delta, and/or uPAR, (ii) I-309, IL-16, MCP-4, MIP-1 delta, CXCL7/NAP-2 and/or uPAR, or (iii) FasL and/or CCL22;
- b) identifying the subject as having an aneurysm if the expression level of (i) I-309, IL-16, IL-1 alpha, MCP-2, MIP-1 delta, and/or uPAR, (ii) I-309, IL-16, MCP-4, MIP-1 delta, CXCL7/NAP-2 and/or uPAR, or (iii) FasL and/or CCL22 is increased relative to a first reference sample;
- c) measuring, in the biological sample, an expression level of one or more cytokines;
- d) determining whether the subject has or is at risk of rupture of the aneurysm;
- and
- e) administering a therapeutically effective amount of an aneurysm inhibitor to the subject.
A method of identifying a subject having or at risk of developing an aneurysm by one or more computing systems, comprising:
- receiving, from a client device via a user interface of a software executing on the client device, one or more inputs associated with the subject;
- determining, based on one or more models, one or more measures regarding aneurysm presence and aneurysm rupture, wherein the one or more measures comprise one or more of a first probability of the subject harboring an aneurysm, a second probability of an ruptured aneurysm in the subject, or a third probability of an aneurysm with impending rupture in the subject;
- and
- sending, to the client device via the user interface, instructions for presenting the one or more determined measures regarding aneurysm presence and aneurysm rupture.
One or more computer-readable non-transitory storage media embodying software that is operable when executed to:
- receive, from a client device via a user interface of a software executing on the client device, one or more inputs associated with the subject;
- determine, based on one or more models, one or more measures regarding aneurysm presence and aneurysm rupture, wherein the one or more measures comprise one or more of a first probability of the subject harboring an aneurysm, a second probability of an ruptured aneurysm in the subject, or a third probability of an aneurysm with impending rupture in the subject;
- and
- send, to the client device via the user interface, instructions for presenting the one or more determined measures regarding aneurysm presence and aneurysm rupture.
A system comprising:
- one or more processors;
- and a non-transitory memory coupled to the processors comprising instructions executable by the processors, the processors operable when executing the instructions to:
- receive, from a client device via a user interface of a software executing on the client device, one or more inputs associated with the subject;
- determine, based on one or more models, one or more measures regarding aneurysm presence and aneurysm rupture, wherein the one or more measures comprise one or more of a first probability of the subject harboring an aneurysm, a second probability of an ruptured aneurysm in the subject, or a third probability of an aneurysm with impending rupture in the subject;
- and
- send, to the client device via the user interface, instructions for presenting the one or more determined measures regarding aneurysm presence and aneurysm rupture.
Dependencies are inferred from the claim text.